geneXplain GmbH

Worldwide providers of top bioinformatics, systems biology and cheminformatics databases & softwares.
#Bioinformatics #multiomics #dataanalysis #biotechnology

[geneXplain GmbH @geneXplain]

We were pleased to see TRANSFAC® used in regulatory enrichment analysis. Study reported MTF-1 & Kaiso motif signals among differentially expressed genes, linking severe dengue progression.
https://t.co/U1n6Knkcyo
https://t.co/cvm5MOj0Wk
#researchupdates #database #manuallycurated

[geneXplain GmbH @geneXplain]

Why some people with inborn errors of immunity respond strongly to mRNA vaccination, while others show weaker humoral responses? TRANSFAC® was used and cited in the regulatory interpretation of these findings.
Paper: https://t.co/f4dMwzrqEa
#GeneRegulation #TranscriptionFactors

[geneXplain GmbH @geneXplain]

Its the final day to bridge the gap between “raw data” & “biological insight” while locking in your annual price (40% off) for future renewals https://t.co/79YGtRdnTF
Lock your 35th Anniversary Pricing: https://t.co/79YGtRdnTF
#Generegulation #realdatabase #transfac #geneXplain

[geneXplain GmbH @geneXplain]

2 days left: Lock it or miss it, If you’re working with omics data, this is not just another tool - it’s how you move from lists to real biological insight.
Click: https://t.co/79YGtRdnTF before April 17, 24:00 to reserve your discount.
#Saleontransfac #Generegulation #research

[geneXplain GmbH @geneXplain]

Dear colleague, Less than 3 days remain to reserve your TRANSFAC discount (https://t.co/79YGtRdnTF), valid for 3 weeks once claimed.
Reserve your discount: https://t.co/79YGtRdnTF before April 17, 24:00 to reserve your discount.
#Generegulation #research #realdatabase #transfac

[geneXplain GmbH @geneXplain]

Is AI predicting drugs? While many AI models can generate a list of "relevant" drugs, they fail to provide the mechanistic reasoning to choose the right one.

TRANSFAC DISEASES: A ecosystem that bridges the gap between DNA regulation and clinical therapy.
#DrugDiscovery #Genomics

[geneXplain GmbH @geneXplain]

Dear Researchers, we’re opening a limited anniversary offer for TRANSFAC®, to support researchers working with multi-omics data.
You can reserve the offer now (5 days) & complete formal procedures afterwards (3 weeks), Secure: https://t.co/79YGtRdnTF
#GENEREGULATION #OMICS #SALE

[geneXplain GmbH @geneXplain]

We’re opening a limited 35-Year Anniversary Offer for TRANSFAC®, designed to support researchers working with multi-omics data.
https://t.co/79YGtRdnTF
+20–40% discount
+Annual price locked
+1–3 hours of expert support
https://t.co/y36q2UgOh9
#GENEREGULATION #OMICSLEADERS #SALE

[geneXplain GmbH @geneXplain]

Next week, TRANSFAC® turns 35. To honour the community that made this possible, GeneXplain is launching the most significant offer in the history of the database.
Subscribe to our Newsletter Here: https://t.co/KFVasEJ6vs
#GeneRegulation #Bioinformatics #ResearchGrant #biotech

[geneXplain GmbH @geneXplain]

In our Genome Enhancer case study, we shifted focus from "what" is changing to "why". By using VCF input and moving beyond standard gene lists, we uncovered thecdrivers behind #Glioblastoma.

Comment "YES" below & we will send you the complete report.
#CancerResearch #MultiOmics

[geneXplain GmbH @geneXplain]

In a recent study, researchers uncovered LCTA, a novel class of compounds targeting thioredoxin reductase, a key enzyme in cancer cell survival.
Read the full story: https://t.co/jBCgyQJHWb
Keep an eye out for our April anniversary offers.
https://t.co/KFVasEJ6vs
#Bioinformatics

[geneXplain GmbH @geneXplain]

𝐓𝐑𝐀𝐍𝐒𝐅𝐀𝐂® 𝐢𝐬 𝐓𝐮𝐫𝐧𝐢𝐧𝐠 “𝟑𝟓”, as the industry leader for tf's and their DNA binding sites, 𝐓𝐑𝐀𝐍𝐒𝐅𝐀𝐂® has been the backbone of gene regulation research for over three decades. B𝐢𝐠𝐠𝐞𝐬𝐭 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐬 are on the way.
#Bioinformatics #GeneRegulation

[geneXplain GmbH @geneXplain]

Looking for "Missing Step" in your Bioinformatics Workflow. We’ve prepared a detailed report walking through this process step-by-step. Drop email & we'll slide it to you.
#DataScience #Biotech #PrecisionMedicine #TranscriptionFactors #Anniversary #Bioinformatics #SystemsBiology

[geneXplain GmbH @geneXplain]

When we see a massive shift in gene expression, we must ask: Which transcription factors are pulling the strings? GeneXplain moved beyond the "list" to analyze the promoter regions of 300 upregulated genes using our MATCH Suite (powered by TRANSFAC®).
Want report? Comment "MATCH"

[geneXplain GmbH @geneXplain]

TRANSFAC®: Leading the Charge in Functional Enrichment, Results were clear: TRANSFAC® significantly surpassed all other databases in identifying regulatory insights.
Read the full paper: https://t.co/PFo9JmTBLl
Explore TRANSFAC®: https://t.co/vnFiWGVw9q
#Epigenetics #mQTL #DNAm

[geneXplain GmbH @geneXplain]

You found 500 differentially expressed genes, but do you know why they changed?
Most studies answer only the first question: Which genes changed?
But the real biological question is what caused those changes?
Read: https://t.co/okXE94bIyj
#SystemsBiology #bioinformatics #Genetics

[geneXplain GmbH @geneXplain]

What if your gene list could tell you the whole disease story? Many studies produce thousands of DEG's. At geneXplain GmbH, we address this challenge by connecting gene expression data to regulatory and signalling networks.
https://t.co/oEuaxGsEtq
#SystemsBiology #Bioinformatics

[geneXplain GmbH @geneXplain]

Discover how GENEXPLAIN’s TRANSFAC Disease package connects TF to specific diseases. This helps researchers find key regulatory networks behind conditions like cancer, diabetes.
Explore: https://t.co/1GbhGZ09WJ
Applications: https://t.co/YwAJ6CZmsk
#Bioinformatics #GeneRegulation

[geneXplain GmbH @geneXplain]

Today, we celebrate the strength, resilience & health of women worldwide. At GeneXplain, we believe that every woman deserves access to equitable healthcare that evolves from adolescence through every milestone of life.
#IWD2026 #geneXplain #womenshealth #equitablehealthcare

[geneXplain GmbH @geneXplain]

Understanding complex connections between diseases & clinical trials is critical for research. HumanPSD provide access to over 1,100,000 clinical trial–disease connections to empower your drug discovery & biomarker research.
https://t.co/sedBzLv08d
#ClinicalTrials #Bioinformatics